The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary results of a two stage phase II study of 18F-DCFPyL PET-MR for enabling oligometastases ablative therapy in subclinical prostate cancer.
 
Rachel Glicksman
No Relationships to Disclose
 
Ur Metser
No Relationships to Disclose
 
Doug Vines
No Relationships to Disclose
 
Rosanna Chan
Stock and Other Ownership Interests - Pfizer (I); Roche (I)
 
John Valliant
No Relationships to Disclose
 
Peter W. M. Chung
Honoraria - Abbvie
Consulting or Advisory Role - Bayer
Research Funding - Abbvie
 
Mary K. Gospodarowicz
Leadership - IBA
Consulting or Advisory Role - IBA
Travel, Accommodations, Expenses - IBA
 
Andrew Bayley
No Relationships to Disclose
 
Charles N Catton
Honoraria - Sanofi
Consulting or Advisory Role - Abbvie; Bayer; Janssen Oncology; Sanofi
Research Funding - Abbvie (Inst)
 
Padraig Richard Warde
No Relationships to Disclose
 
Joelle Antoine Helou
No Relationships to Disclose
 
Nafisha Lalani
No Relationships to Disclose
 
David E Green
No Relationships to Disclose
 
Nathan Perlis
No Relationships to Disclose
 
Neil Eric Fleshner
Honoraria - Abbvie; Amgen; Astellas Medivation; Bayer; Ferring; Janssen Oncology; Sanofi
Consulting or Advisory Role - Hybridyne Health
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Ferring (Inst); Janssen Oncology (Inst); Nucleix (Inst); Progenix (Inst); Spectracure (Inst)
 
Robert James Hamilton
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Janssen
Research Funding - Bayer; Janssen
Travel, Accommodations, Expenses - Janssen
 
Alexandre Zlotta
No Relationships to Disclose
 
Antonio Finelli
Stock and Other Ownership Interests - Abbvie; Bristol-Myers Squibb
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Ipsen; Janssen Oncology; Roche Canada; Tersera
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; Bayer; Ipsen; Janssen Oncology; Roche Canada; Tersera
 
David A. Jaffray
Stock and Other Ownership Interests - NantCell
Research Funding - Elekta (Inst); GE Healthcare (Inst); RaySearch Laboratories (Inst); Riley (Inst)
Patents, Royalties, Other Intellectual Property - Acumyn; Elekta; iRT; Modus Medical Devices; RaySearch Laboratories; University Health Network; William Beaumont Hospital
 
Alejandro Berlin
No Relationships to Disclose